Showing results (61-70 of 87) with videos related to
Sort By:
Pageof 9
Journal for Immunotherapy of Cancer|August 24, 2022
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatmentsSylvain Nguyen, Mathieu F Chevalier, Sulayman Benmerzoug, et al.European Urology Open Science|November 26, 2021
Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Laura Villier, et al.European Urology Focus|June 20, 2021
Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer PatientsSulayman Benmerzoug, Mathieu F Chevalier, Maëlle Verardo, et al.Investigative and Clinical Urology|June 30, 2021
Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort studyArnas Rakauskas, Thomas Tawadros, Ilaria Lucca, et al.World Journal of Urology|January 28, 2026
How safe is teaching radical cystectomy? : Results from the prospective Swiss society of urology databaseMatteo Scherrer, Lujza Brunaiova, Marc Furrer, et al.World Journal of Urology|February 17, 2016
Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinomaHarun Fajkovic, Shahrokh F Shariat, Tobias Klatte, et al.The Journal of Urology|April 3, 2013
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trialPaolo Gontero, Marco Oderda, Anja Mehnert, et al.Urologic Oncology|March 27, 2017
Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancerFrancesco Soria, Ilaria Lucca, Marco Moschini, et al.Urologic Oncology|December 3, 2014
Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic modelIlaria Lucca, Shahrokh F Shariat, Alberto Briganti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2016
Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer PatientsLaurent Derré, Valérie Cesson, Ilaria Lucca, et al.Pageof 9